{
    "Trade/Device Name(s)": [
        "HemosIL von Willebrand Factor Antigen"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K200033",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992704"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGP"
    ],
    "Summary Letter Date": "July 17, 2020",
    "Summary Letter Received Date": "July 20, 2020",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7290"
    ],
    "Regulation Name(s)": [
        "Factor deficiency test"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "von Willebrand Factor Antigen"
    ],
    "Specimen Type(s)": [
        "Citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IL Coagulation Systems",
        "ACL Family Systems",
        "ACL TOP Family",
        "ACL TOP Family 50 Series"
    ],
    "Method(s)/Technology(ies)": [
        "Latex particle enhanced immunoturbidimetric assay",
        "Automated latex enhanced immunoassay"
    ],
    "Methodologies": [
        "Immunoturbidimetric assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL von Willebrand Factor Antigen, an automated latex enhanced immunoassay for quantifying von Willebrand Factor Antigen in citrated plasma, with modified Rheumatoid Factor interference claims.",
    "Indications for Use Summary": "Automated latex enhanced immunoassay for the quantitative determination of von Willebrand Factor Antigen (VWF:Ag) in human citrated plasma on IL Coagulation Systems.",
    "fda_folder": "Hematology"
}